Drugs that have constraints in addition to prior authorization, quantity limitations, and action therapy connected with Each individual prescription.

pentobarbital will lower the level or outcome of etravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

pentobarbital will decrease the extent or effect of pioglitazone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unfamiliar.

pentobarbital will lower the level or influence of ramelteon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unknown.

pentobarbital will reduce the extent or influence of temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

Aged or debilitated people could respond to barbiturates with marked depression, pleasure, and confusion; in certain individuals, barbiturates regularly deliver excitement in lieu of melancholy

pentobarbital will reduce the level or impact of ziprasidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unidentified.

pentobarbital will minimize the extent or influence of loratadine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

pentobarbital will minimize the extent or impact of darifenacin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

pentobarbital will lessen the level or result of artemether/lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration with robust CYP3A4 inducers may end up in reduced serum concentrations and loss of antimalarial efficacy

pentobarbital will minimize the extent or outcome of levamlodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will lower the extent or result of verapamil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will lower the level or outcome of apremilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration with robust CYP inducers brings about a substantial reduce of systemic publicity of apremilast, which may end in read more loss of efficacy

pentobarbital will lower the extent or result of buprenorphine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.